 Usefulness verapamil congestive heart failure abnormal ventricular diastolic filling normal ventricular systolic performance Normal ventricular systolic performance impaired ventricular diastolic filling present substantial number patients congestive heart failure CHF effect oral verapamil subset men mean age years CHF intact ventricular function ejection fraction abnormal diastolic filling peak rate end-diastolic volumes second edv/s placebo-controlled double-blind crossover trial patients underwent echocardiography significant valvular disease stress scintigraphy major active ischemia values exercise capacity vs minutes baseline peak filling rate vs edv/s baseline values minutes edv/s difference significant Improvement baseline objective clinico-radiographic heart failure score scale verapamil median improvement score vs Mean ejection fraction systolic blood pressure unchanged baseline diastolic blood pressure heart rate small degree Verapamil therapeutic efficacy patients CHF systolic function impaired diastolic filling